NCT03670082View on ClinicalTrials.gov

Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

December 21, 2018

Study Completion Date

January 13, 2019

Conditions
Healthy
Interventions
DRUG

Lu AF35700

20 mg Lu AF35700 single oral dose

DRUG

Lu AF35700 iv

100 μg \[14C\]-Lu AF35700 (4.7 μCi/174 kBq) single intravenous micro-dose

Trial Locations (1)

Unknown

Covance, Leeds

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT03670082 - Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State | Biotech Hunter | Biotech Hunter